Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
The association of depression with a diagnosis of and subsequent treatment for prostate cancer is well appreciated, but the prevalence of that depression and the burden it places on men with prostate cancer over time has been less well documented.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: depression, mortality, outcome, risk | 5 Comments »
A new paper in the European Journal of Cancer suggests that men with prostate cancer are at increased risk for depression, for post-traumatic stress disorder, and for use of antidepressant drugs compared to age-matched controls.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: anxiety, depression, post-traumatic stress disorder, risk, Sweden, Treatment | 3 Comments »
It is unlikely to come as any big surprise to the average prostate cancer patient who was potent before first-line therapy but has erectile dysfunction (ED) afterward that there might be an association between ED and depression after initial treatment for localized prostate cancer.
Filed under: Living with Prostate Cancer | Tagged: depression, ED, erectile dysfunction | 6 Comments »
There has been good evidence that older cancer patients report less “distress” than younger cancer patients. However, there has been very little research to date into the distinctions among general distress, anxiety, and depression in aging prostate cancer patients.
Filed under: Living with Prostate Cancer | Tagged: age, anxiety, depression, distress | Leave a Comment »
One of the issues that worries people about active surveillance and other forms of “non-interventional” management for prostate cancer is whether patients will suffer unduly from anxiety and distress while living with “untreated” cancer. We know that there are patients who have been on such protocols long-term who do not; we also know that there [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active surveillance, anxiety, depression, distress | 6 Comments »
Looking through my assorted notes from the meeting this morning after getting home late last night, there are four other poster presentations that are worth commenting on very specifically, and then a general comment that I would add.
Filed under: Management, Treatment | Tagged: abiraterone, active surveillance, anxiety, cost, depression, MDV3100, radical prostatectomy | Leave a Comment »
We have separately commented on a Swedish pilot study showing that men treated with captopril following radical prostatectomy had a significant reduction in risk of biochemical recurrence. Other reports today deal with: The potential of contrast enhanced eMRI in diagnosis and monitoring Whether we can better identify high-risk patients with localized disease for curative surgery Early-stage [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: "high risk", contrast-enhanced eMRI, depression, hot flashes, mortality, surgery | Leave a Comment »
The important news today appears to be clear confirmation that a high- (or low-) fiber diet won’t affect your risk for prostate cancer (at least, not over an 8-year timeframe). In other news today: Prostate weight may impact risk for recurrence following surgery Just over 25 percent of patients receiving hormone therapy will be diagnosed with [...]
Filed under: Living with Prostate Cancer, Management, Prevention, Tips, Treatment | Tagged: androgen, depression, deprivation, diet, fiber, positive surgical margin, risk | Leave a Comment »
Newly published studies today include data on: Risk for patients with prostate atypia on biopsy having a subsequent diagnosis of prostate cancer Patterns of failure of patients treated with brachytherapy for localized disease Quality of life following differing types of radiotherapy Second-line antiandrogen therapy following initial failure of a first-line antiandrogen in advanced prostate cancer [...]
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: androgen deprivation, antiandrogen, atypia, bicalutamide, brachytherapy, cancer, depression, fatigue, flutamide, irritability, mood, prostate, quality of life, radiotherapy | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site